PRAMEF7 Activators
PRAMEF7, or PRAME family member 7, is a gene that has garnered interest in the scientific community for its role in various cellular processes. This protein-coding gene is predicted to participate in the negative regulation of apoptotic processes and the positive regulation of cell population proliferation, as well as having a role in the negative regulation of transcription that is DNA-templated. It is thought to be active in the cytoplasm and has been observed to have low expression in reference data sets. PRAMEF7's expression patterns and functions suggest it could be a crucial player in cellular homeostasis and growth. The regulation of PRAMEF7 expression is a complex and finely tuned process, potentially responsive to a range of biochemical signals and environmental stimuli.
The exploration into the induction of PRAMEF7 expression has led to the identification of various chemical activators that could, directly or indirectly, increase the transcription of this gene. Compounds such as 5-Aza-2'-deoxycytidine (Decitabine) and Trichostatin A are known as epigenetic modifiers that can alter the chromatin state, potentially leading to the upregulation of PRAMEF7. Similarly, signaling molecules like Forskolin may increase cAMP levels, which could enhance PRAMEF7 expression through the activation of transcription factors. Naturally occurring substances, including Epigallocatechin gallate (EGCG) and Resveratrol, have been shown to have broad effects on gene expression and could also play a role in stimulating PRAMEF7 transcription. Forskolin can activate adenylate cyclase, thus increasing cAMP in cells and potentially affecting PRAMEF7 expression. On the other hand, dietary components like Sulforaphane, found in cruciferous vegetables, could activate pathways that lead to the expression of PRAMEF7 by binding to and activating transcription factors. These chemicals represent a diverse array of molecules that can elicit a cellular response, culminating in the induction of PRAMEF7 expression, which underscores the intricate web of interactions governing gene expression within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine may upregulate PRAMEF7 by inhibiting DNA methyltransferase, thus reducing methylation at the gene's promoter region and encouraging transcriptional activation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could stimulate PRAMEF7 expression by preventing histone deacetylation, leading to a more transcriptionally active chromatin state around the PRAMEF7 locus. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid could induce PRAMEF7 expression through retinoic acid receptors that bind to retinoic acid response elements in the promoter region, enhancing gene transcription. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin might increase PRAMEF7 levels by raising intracellular cAMP, which activates protein kinase A and subsequent phosphorylation of transcription factors that stimulate PRAMEF7's promoter. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate could elevate PRAMEF7 transcription by altering the activity of transcription factors and DNA methyltransferases, leading to changes in gene expression profiles. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate might upregulate PRAMEF7 by inhibiting histone deacetylase, which would result in hyperacetylation of histones near the PRAMEF7 gene and activation of its transcription. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone could stimulate PRAMEF7 expression by engaging glucocorticoid receptors that interact with glucocorticoid response elements on the PRAMEF7 gene promoter. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin might induce PRAMEF7 expression by inhibiting NF-κB signaling, which could lead to the attenuation of repressive effects on genes like PRAMEF7 that are involved in cell proliferation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could upregulate PRAMEF7 by activating the SIRT1 protein, leading to deacetylation of transcription factors or co-regulators involved in the expression of PRAMEF7. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride may stimulate PRAMEF7 expression by activating the Wnt/beta-catenin signaling pathway, which can lead to the transcription of Wnt target genes, including potentially PRAMEF7. | ||||||